A Genuinely Complex Landscape
While telehealth clinical care has matured considerably, the regulatory framework governing what can be prescribed through virtual visits, particularly for controlled substances, remains a genuinely complex and evolving landscape that varies significantly and can create confusion for both patients and providers navigating what is and is not currently permitted through telehealth encounters.
The Controlled Substance Challenge
Prescribing controlled substances, including many medications for pain, anxiety, and importantly medication-assisted treatment for opioid use disorder, through telehealth involves particular regulatory scrutiny given legitimate concerns about diversion and inappropriate prescribing, alongside the significant benefit these flexibilities have provided for patients who would otherwise face substantial access barriers, especially for addiction treatment where access is often time-critical.
What Patients Should Know
Given the evolving nature of telehealth prescribing regulation, patients relying on telehealth for ongoing prescriptions, particularly controlled substances, should stay informed about current rules and maintain established relationships with providers who can navigate the regulatory requirements appropriately. As policymakers continue refining this framework, balancing access with appropriate oversight remains an ongoing process rather than a settled matter. Facilities can source pharmacy supplies and diagnostic equipment from our catalog.
